Toxer 90

Hauptinformation

  • Handelsname:
  • Toxer 90
  • Darreichungsform:
  • SL Wasserlösliches Konzentrat
  • Verwenden für:
  • Pflanzen
  • Art der Medizin:
  • Agrochemisch

Dokumenten

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Toxer 90
    Schweiz
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiegruppe:
  • Herbizid

Weitere Informationen

Status

  • Quelle:
  • UFAG - Ufficio federale dell'agricoltura. OFAG - Office fédéral de l'agriculture. BLW - Bundesamt für Landwirtschaft.
  • Zulassungsnummer:
  • W-6312
  • Letzte Änderung:
  • 15-11-2018

Packungsbeilage

Handelsbezeichnung: Toxer 90

Pflanzenschutzmittelverzeichnis (Stand: 06.11.2018)

Produktkategorie:

Bewilligungsinhaber:

Eidg. Zulassungsnummer:

Herbizid

Omya (Schweiz) AG

W-6312

Stoff(e):

Gehalt:

Formulierungscode:

Wirkstoff: Glyphosat

8.6 % 90 g/l

[als 11.6% Glyphosat-Isopropylammoniumsalz

(121.5 g / l)]

SL Wasserl

sliches

Konzentrat

Anwendungen

A

Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

B Brombeere

Einj

hrige

Dicotyledonen (Unkr

uter)

Einj

hrige

Monocotyledonen (Ungr

ser)

Gemeine Quecke

Aufwandmenge: 8 - 12 l/ha

1, 2

B Brombeere

Mehrj

hrige

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

1, 2

Kernobst

Steinobst

Einj

hrige

Dicotyledonen (Unkr

uter)

Einj

hrige

Monocotyledonen (Ungr

ser)

Gemeine Quecke

Aufwandmenge: 8 - 12 l/ha

1, 2

Kernobst

Steinobst

Mehrj

hrige

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

1, 2

A

Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

W Ertragsreben

Einj

hrige

Dicotyledonen (Unkr

uter)

Einj

hrige

Monocotyledonen (Ungr

ser)

Gemeine Quecke

Aufwandmenge: 8 - 12 l/ha

1, 2

W Ertragsreben

Mehrj

hrige

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

1, 2

G Brache

Einj

hrige

Dicotyledonen (Unkr

uter)

Einj

hrige

Monocotyledonen (Ungr

ser)

Gemeine Quecke

Aufwandmenge: 8 - 12 l/ha

1, 3

G Brache

Mehrj

hrige

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

1, 3

Brache

Einj

hrige

Dicotyledonen (Unkr

uter)

Einj

hrige

Monocotyledonen (Ungr

ser)

Gemeine Quecke

Aufwandmenge: 8 - 12 l/ha

1, 3

Brache

Mehrj

hrige

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

1, 3

Mais

Einj

hrige

Dicotyledonen (Unkr

uter)

Aufwandmenge: 8 - 12 l/ha

Anwendung: Bei der Saat.

1, 4, 5

A

Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

Einj

hrige

Monocotyledonen (Ungr

ser)

Gemeine Quecke

Mais

Mehrj

hrige

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

Anwendung: Bei der Saat.

1, 4, 5

Wiesen und Weiden

Dicotyledonen (Unkr

uter)

Monocotyledonen (Ungr

ser)

Konzentration: 2 - 6 %

Anwendung: Mit R

ckenspritze.

1, 6, 7

Wiesen und Weiden

Dicotyledonen (Unkr

uter)

Monocotyledonen (Ungr

ser)

Konzentration: 20 - 40 %

Anwendung: Mit

Handspritzger

ten.

1, 6, 7

Wiesen und Weiden

Dicotyledonen (Unkr

uter)

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

Anwendung: Fl

chenbehandlung; vor

Neuansaat.

1, 3

ume und Str

ucher

(ausserhalb Forst)

Rosen

Einj

hrige

Dicotyledonen (Unkr

uter)

Einj

hrige

Monocotyledonen (Ungr

ser)

Gemeine Quecke

Aufwandmenge: 8 - 12 l/ha

1, 2

ume und Str

ucher

(ausserhalb Forst)

Rosen

Mehrj

hrige

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

1, 2

Brache

Einj

hrige

Dicotyledonen (Unkr

uter)

Einj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 8 - 12 l/ha

1, 3

A

Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

Gemeine Quecke

Brache

Mehrj

hrige

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

1, 3

Forstliche Pflanzg

rten

Einj

hrige

Dicotyledonen (Unkr

uter)

Einj

hrige

Monocotyledonen (Ungr

ser)

Gemeine Quecke

Aufwandmenge: 8 - 12 l/ha

1, 2

Forstliche Pflanzg

rten

Mehrj

hrige

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

1, 2

Auf und an National- und

Kantonsstrassen

Einj

hrige

Dicotyledonen (Unkr

uter)

Einj

hrige

Monocotyledonen (Ungr

ser)

Gemeine Quecke

Aufwandmenge: 8 - 12 l/ha

1, 4, 8

Auf und an National- und

Kantonsstrassen

Mehrj

hrige

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Aufwandmenge: 16 - 40 l/ha

1, 4, 8

schungen und Gr

nstreifen entlang von

Verkehrswegen (gem.

ChemRRV)

Einj

hrige

Dicotyledonen (Unkr

uter)

Einj

hrige

Monocotyledonen (Ungr

ser)

Gemeine Quecke

Aufwandmenge: 8 - 12 l/ha

1, 4, 8

schungen und Gr

Mehrj

hrige

Aufwandmenge: 16 - 40 l/ha

1, 4, 8

A

Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

nstreifen entlang von

Verkehrswegen (gem.

ChemRRV)

Dicotyledonen (Unkr

uter)

Mehrj

hrige

Monocotyledonen (Ungr

ser)

Auflagen und Bemerkungen:

Keine Niederschl

ge w

hrend mindestens 6 Stunden nach der Behandlung.

Behandlung sp

testens bis Ende August. Es d

rfen keine gr

nen Teile der Kulturpflanzen

mit dem Herbizid in Kontakt kommen.

Behandlung bis sp

testens 2 Wochen vor der Saat oder Pflanzung.

Die Aufwandmenge bezieht sich auf die effektiv zu behandelnde Fl

che.

Behandlung der unbearbeiteten Zwischenreihen bei der Streifenfr

ssaat.

Beweidung oder Schnitt (Gr

nfutter oder Konservierung) fr

hestens 3 Wochen nach der

Behandlung. Ausnahme: F

r nicht laktierende Tiere betr

gt die Wartefrist 2 Wochen.

Einzelpflanzenbehandlung.

ss Chemikalien-Risikoreduktions-Verordnung (ChemRRV): Nur

Einzelpflanzenbehandlung anderweitig nicht bek

mpfbarer Problempflanzen.

Gefahrenkennzeichnungen:

Bewilligt f

r die nichtberufliche Verwendung.

Darf nicht in die H

nde von Kindern gelangen.

EUH 401 Zur Vermeidung von Risiken f

r Mensch und Umwelt die Gebrauchsanleitung

einhalten.

H412 Sch

dlich f

r Wasserorganismen, mit langfristiger Wirkung.

SP 1 Mittel und/oder dessen Beh

lter nicht in Gew

sser gelangen lassen.

Im Zweifelsfall gelten einzig die Originaldokumente der Zulassung. Die Erw

hnung eines Produktes,

Wirkstoffes oder einer Firma stellt keine Empfehlung dar und bedeutet nicht, dass sich das Produkt im

Verkauf befindet.

17-11-2018

Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from a genetically modified Aspergillus oryzae (strain NZYM‐FA)

Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from a genetically modified Aspergillus oryzae (strain NZYM‐FA)

Published on: Fri, 16 Nov 2018 The food enzyme is an endo‐1,4‐β‐xylanase (EC 3.2.1.8) produced with a genetically modified strain of Aspergillus oryzae by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. This xylanase is intended to be used in baking and cereal‐based processes. Based on the proposed maximum use levels, dietary exposure to the food enzyme–total organic solids (TOS) was e...

Europe - EFSA - European Food Safety Authority Publications

15-11-2018

Safety evaluation of the food enzyme maltogenic amylase from a genetically modified Bacillus subtilis (strain NZYM‐OC)

Safety evaluation of the food enzyme maltogenic amylase from a genetically modified Bacillus subtilis (strain NZYM‐OC)

Published on: Wed, 14 Nov 2018 The food enzyme maltogenic amylase (glucan 1,4‐a‐maltohydrolase; EC 3.2.1.133) is produced with a genetically modified Bacillus subtilis strain NZYM‐OC by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production microorganism and recombinant DNA. This maltogenic amylase is intended to be used in baking processes. Based on the maximum use levels recommended, dietary exposure to the food enzyme–...

Europe - EFSA - European Food Safety Authority Publications

15-11-2018

Assessment of genetically modified maize MZHG0JG for food and feed uses, import and processing under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2016‐133)

Assessment of genetically modified maize MZHG0JG for food and feed uses, import and processing under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2016‐133)

Published on: Wed, 14 Nov 2018 The scope of application EFSA‐GMO‐DE‐2016‐133 is for food and feed uses, import and processing of genetically modified (GM) maize MZHG0JG in the European Union. Maize MZHG0JG was developed to confer tolerance to the herbicidal active substances glyphosate and glufosinate‐ammonium. The molecular characterisation data and bioinformatic analyses do not identify issues requiring food/feed safety assessment. None of the identified differences in the agronomic/phenotypic and com...

Europe - EFSA - European Food Safety Authority Publications

15-11-2018

Safety evaluation of the food enzyme maltogenic amylase from a genetically modified Bacillus subtilis (strain NZYM‐SO)

Safety evaluation of the food enzyme maltogenic amylase from a genetically modified Bacillus subtilis (strain NZYM‐SO)

Published on: Wed, 14 Nov 2018 The food enzyme maltogenic amylase (glucan 1,4‐α‐maltohydrolase; EC 3.2.1.133) is produced with a genetically modified Bacillus subtilis strain NZYM‐SO by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production microorganism and recombinant DNA. This maltogenic amylase is intended to be used in baking processes. Based on the maximum use levels, dietary exposure to the food enzyme–total organi...

Europe - EFSA - European Food Safety Authority Publications

15-11-2018

Safety evaluation of the food enzyme acetolactate decarboxylase from a genetically modified Bacillus licheniformis (strain NZYM‐JB)

Safety evaluation of the food enzyme acetolactate decarboxylase from a genetically modified Bacillus licheniformis (strain NZYM‐JB)

Published on: Wed, 14 Nov 2018 The food enzyme acetolactate decarboxylase (α‐acetolactate decarboxylase; EC 4.1.1.5) is produced with a genetically modified Bacillus licheniformis strain NZYM‐JB by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. This acetolactate decarboxylase is intended to be used in distilled alcohol production and brewing processes. Residual amounts of total organi...

Europe - EFSA - European Food Safety Authority Publications

1-11-2018

Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from a genetically modified Bacillus subtilis (strain LMG S‐24584)

Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from a genetically modified Bacillus subtilis (strain LMG S‐24584)

Published on: Wed, 31 Oct 2018 00:00:00 +0100 The food enzyme endo‐1,4‐β‐xylanase (EC 3.2.1.8) is produced with the genetically modified Bacillus subtilis strain LMG S‐24584 by Puratos N. V. The genetic modifications do not give rise to safety concerns. The Panel noted that, although the production strain was not detected in the food enzyme, recombinant DNA was present in all batches of the food enzyme tested. The food enzyme is intended to be used in baking processes. Based on the maximum use levels re...

Europe - EFSA - European Food Safety Authority Publications

1-11-2018

Safety evaluation of the food enzyme glucan 1,4‐α‐glucosidase from a genetically modified Aspergillus niger (strain NZYM‐BW)

Safety evaluation of the food enzyme glucan 1,4‐α‐glucosidase from a genetically modified Aspergillus niger (strain NZYM‐BW)

Published on: Wed, 31 Oct 2018 00:00:00 +0100 The food enzyme glucan 1,4‐α‐glucosidase (EC 3.2.1.3) is produced with the genetically modified Aspergillus niger strain NZYM‐BW by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. The glucan 1,4‐α‐glucosidase food enzyme is intended to be used in distilled alcohol production and starch processing for the production of glucose syrups. Residu...

Europe - EFSA - European Food Safety Authority Publications

1-11-2018

Safety of the food enzyme glucoamylase from a genetically modified Aspergillus niger (strain NZYM‐BF)

Safety of the food enzyme glucoamylase from a genetically modified Aspergillus niger (strain NZYM‐BF)

Published on: Wed, 31 Oct 2018 00:00:00 +0100 The food enzyme glucoamylase (glucan 1,4‐α‐glucosidase; EC 3.2.1.3) is produced with the genetically modified strain of Aspergillus niger by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. This glucoamylase is intended to be used in brewing processes and in starch processing for glucose syrups production. Residual amounts of total organic s...

Europe - EFSA - European Food Safety Authority Publications

1-11-2018

Safety evaluation of the food enzyme α‐amylase from a genetically modified Aspergillus niger (strain NZYM‐MC)

Safety evaluation of the food enzyme α‐amylase from a genetically modified Aspergillus niger (strain NZYM‐MC)

Published on: Wed, 31 Oct 2018 00:00:00 +0100 The food enzyme alpha‐amylase (4‐α‐d‐glucan glucanohydrolase; EC 3.2.1.1) is produced with the genetically modified strain of Aspergillus niger by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. This α‐amylase is intended to be used in starch processing for glucose syrups production, beverage alcohol (distilling) processes and baking proces...

Europe - EFSA - European Food Safety Authority Publications

20-10-2018

Scientific Opinion of Flavouring Group Evaluation 411 (FGE.411): 2‐(4‐methylphenoxy)‐N‐(1H‐pyrazol‐3‐yl)‐N‐(thiophen‐2‐ylmethyl)acetamide from chemical group 30 (miscellaneous substances)

Scientific Opinion of Flavouring Group Evaluation 411 (FGE.411): 2‐(4‐methylphenoxy)‐N‐(1H‐pyrazol‐3‐yl)‐N‐(thiophen‐2‐ylmethyl)acetamide from chemical group 30 (miscellaneous substances)

Published on: Fri, 19 Oct 2018 00:00:00 +0200 EFSA was requested to deliver a scientific opinion on the implications for human health of the flavouring substance 2‐(4‐methylphenoxy)‐N‐(1H‐pyrazol‐3‐yl)‐N‐(thiophen‐2‐ylmethyl)acetamide [FL‐no: 16.133], in the Flavouring Group Evaluation 411 (FGE.411), according to Regulation (EC) No 1331/2008 of the European Parliament and of the Council. The substance has not been reported to occur in natural source materials of botanical or animal origin. It is intende...

Europe - EFSA - European Food Safety Authority Publications

17-10-2018

Lumpy skin disease: scientific and technical assistance on control and surveillance activities

Lumpy skin disease: scientific and technical assistance on control and surveillance activities

Published on: Tue, 16 Oct 2018 00:00:00 +0200 The duration of the vaccination campaign sufficient to eliminate lumpy skin disease (LSD) mainly depends on the vaccination effectiveness and coverage achieved. By using a spread epidemiological model, assuming a vaccination effectiveness of 65%, with 50% and 90% coverage, 3 and 4 years campaigns, respectively, are needed to eliminate LSD. When vaccination effectiveness is 80% to 95%, 2 years of vaccination at coverage of 90% is sufficient to eliminate LSD vir...

Europe - EFSA - European Food Safety Authority Publications

7-9-2018

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to Product/Label Mix-Up

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to Product/Label Mix-Up

Camber Pharmaceuticals, Inc. is voluntarily recalling one single lot of Montelukast Sodium Tablets, USP 10mg, to the consumer level. This recall of one batch of Montelukast Sodium Tablets, USP 10mg, lot# MON17384 Exp. 12/31/2019, was prompted because a complaint of a sealed bottle labeled as Montelukast 10mg 30 ct found to contain 90 tablets of Losartan Potassium Tablets, USP 50mg

FDA - U.S. Food and Drug Administration

10-8-2018

Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration

Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration

Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg, & 120 mg to the wholesale level. These products are being recalled as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd., which as a result of a 2017 inspection were found to have deficiencies with Current Good Ma...

FDA - U.S. Food and Drug Administration

3-8-2018

Scientific guideline:  Ledipasvir/sofosbuvir film-coated tablet 90 mg/400 mg product-specific bioequivalence guidance, adopted

Scientific guideline: Ledipasvir/sofosbuvir film-coated tablet 90 mg/400 mg product-specific bioequivalence guidance, adopted

Ledipasvir/sofosbuvir film-coated tablet 90 mg/400 mg product-specific bioequivalence guidance

Europe - EFSA - European Food Safety Authority EFSA Journal

29-5-2018

Rote-Hand-Brief zu mycophenolatmofetil-(MMF)/mycophenolsäurehaltigen Arzneimitteln (MPA): Angepasste Empfehlungen zur Kontrazeption

Rote-Hand-Brief zu mycophenolatmofetil-(MMF)/mycophenolsäurehaltigen Arzneimitteln (MPA): Angepasste Empfehlungen zur Kontrazeption

Da Mycophenolatmofetil (MMF) und Mycophenolsäure (MPA) genotoxisch sind, wird bei männlichen Patienten empfohlen, dass der Patient oder dessen Partnerin während der Behandlung und für mindestens 90 Tage nach Beendigung der Behandlung eine zuverlässige Verhütungsmethode anwendet.

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

12-11-2018

Somatuline Autogel® 60 mg/90 mg/120 mg

Rote - Liste

25-9-2018

Zonegran (Eisai GmbH)

Zonegran (Eisai GmbH)

Zonegran (Active substance: zonisamide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)6285 of Tue, 25 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/577/T/90

Europe -DG Health and Food Safety

5-9-2018

#FDA announces draft guidance: Consideration of Uncertainty in Making Benefit-Risk Determinations in #MedicalDevice Premarket Approvals. The document is now open for comment for 90 days. Click the link to review the draft guidance and provide comments:  h

#FDA announces draft guidance: Consideration of Uncertainty in Making Benefit-Risk Determinations in #MedicalDevice Premarket Approvals. The document is now open for comment for 90 days. Click the link to review the draft guidance and provide comments: h

#FDA announces draft guidance: Consideration of Uncertainty in Making Benefit-Risk Determinations in #MedicalDevice Premarket Approvals. The document is now open for comment for 90 days. Click the link to review the draft guidance and provide comments: https://go.usa.gov/xPcpT  pic.twitter.com/hAuLWaIYiK

FDA - U.S. Food and Drug Administration

27-7-2018

Mysimba 8 mg/90 mg Retardtabletten

Rote - Liste

26-7-2018

Harvoni® 90 mg/400 mg Filmtabletten

Rote - Liste

3-7-2018

Efficib (Merck Sharp and Dohme B.V.)

Efficib (Merck Sharp and Dohme B.V.)

Efficib (Active substance: sitagliptin / metformin hydrochloride) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018) 4254 of Tue, 03 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/896/T/90

Europe -DG Health and Food Safety

3-7-2018

Aerius (Merck Sharp and Dohme B.V.)

Aerius (Merck Sharp and Dohme B.V.)

Aerius (Active substance: desloratadine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018) 4255 of Tue, 03 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/313/T/90

Europe -DG Health and Food Safety

3-7-2018

Janumet (Merck Sharp and Dohme B.V.)

Janumet (Merck Sharp and Dohme B.V.)

Janumet (Active substance: sitagliptin / metformin hydrochloride) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018) 4251 of Tue, 03 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/861/T/90

Europe -DG Health and Food Safety

22-6-2018

First continuous glucose monitoring system that includes a fully implantable glucose sensor that can be worn up to 90 days approved today.  #cgm #diabetes #fda #medicaldevice  https://go.usa.gov/xUqg5 pic.twitter.com/6zs99z2Dlz

First continuous glucose monitoring system that includes a fully implantable glucose sensor that can be worn up to 90 days approved today. #cgm #diabetes #fda #medicaldevice https://go.usa.gov/xUqg5 pic.twitter.com/6zs99z2Dlz

First continuous glucose monitoring system that includes a fully implantable glucose sensor that can be worn up to 90 days approved today. #cgm #diabetes #fda #medicaldevice https://go.usa.gov/xUqg5  pic.twitter.com/6zs99z2Dlz

FDA - U.S. Food and Drug Administration

20-6-2018

Brilique® 90 mg Schmelztabletten

Rote - Liste

20-6-2018

Brilique® 90 mg Filmtabletten

Rote - Liste